Metaperex

Alpha-Tocopherol, the active ingredient in Metaperex, is a nutritional supplement presented as an unspecified oral formulation for adult use. It functions as a potent antioxidant, helping to protect cell membranes from oxidative damage and supporting overall nutritional health.

GNH USA supplies Metaperex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured products that meet EU regulatory standards.

Metaperex (alpha‑tocopherol) is used to address conditions related to oxidative stress and vitamin E deficiency.

- Vitamin E deficiency: restores adequate levels of alpha‑tocopherol in individuals with documented deficiency. - Oxidative stress: provides antioxidant support to help protect cells from free‑radical damage. - Skin health: supports maintenance of healthy skin by reducing oxidative injury.

Alpha‑tocopherol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools. - Headache: transient head discomfort. - Skin irritation: mild rash or itching at the site of contact.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or anaphylaxis. - Bleeding tendency: increased risk of hemorrhage, especially with anticoagulants. - Hepatic dysfunction: elevated liver enzymes or jaundice.

When using Metaperex, consider the following precautions to ensure safe and effective use.

- Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss with a physician, as the compound may be excreted in milk. - Anticoagulant therapy: monitor coagulation parameters due to potential enhanced bleeding. - High-dose use: avoid exceeding recommended amounts to prevent toxicity. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Alpha‑tocopherol may interact with certain medications, influencing their efficacy or safety.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect may raise bleeding risk. - Chemotherapy agents (e.g., cyclophosphamide): may reduce therapeutic efficacy. - Statins: potential for increased muscle toxicity.

Moderate Interactions (Monitor Closely): - Vitamin K antagonists other than warfarin: monitor clotting parameters. - High‑dose vitamin C: may affect antioxidant balance. - Lipid‑lowering agents (e.g., fibrates): observe for altered lipid profiles.